Karyopharm Therapeutics

www.karyopharm.com
85 Wells Ave., Suite 210
Newton, MA 02459-3298

Company Info

Phone
(617) 658-0600

Year Established
2009

Ticker
KPTI

Exchange
NASDAQ

Contacts

Richard Paulson, MBA, PhD
President & CEO

Stuart Poulton
Chief Development Operations Officer

Mike Mano, JD
General Counsel

Sohanya Cheng
CCO

Reshma Rangwala, MD, PhD
CMO

Lori Macomber
CFO

Company Description

Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions.